Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara.
Pharmaceuticals (Basel). 2022 Mar 15;15(3):354. doi: 10.3390/ph15030354.
Pharmaceuticals (Basel). 2022.
PMID: 35337151
Free PMC article.
Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized With DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins.
García-Arriaza J, Marín MQ, Merchán-Rubira J, Mascaraque SM, Medina M, Ávila J, Hernández F, Esteban M.
García-Arriaza J, et al.
Vaccines (Basel). 2020 Mar 13;8(1):127. doi: 10.3390/vaccines8010127.
Vaccines (Basel). 2020.
PMID: 32183198
Free PMC article.
Item in Clipboard
An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design.
Pérez P, Marín MQ, Lázaro-Frías A, Sorzano CÓS, Di Pilato M, Gómez CE, Esteban M, García-Arriaza J.
Pérez P, et al.
Vaccines (Basel). 2019 Dec 6;7(4):208. doi: 10.3390/vaccines7040208.
Vaccines (Basel). 2019.
PMID: 31817622
Free PMC article.
Item in Clipboard
Cite
Cite